Agilon Health (AGL) Return on Equity (2020 - 2025)
Agilon Health (AGL) has disclosed Return on Equity for 6 consecutive years, with 0.06% as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Return on Equity rose 8.0% year-over-year to 0.06%, compared with a TTM value of 0.06% through Dec 2025, up 8.0%, and an annual FY2025 reading of 0.05%, up 6.0% over the prior year.
- Return on Equity was 0.06% for Q4 2025 at Agilon Health, up from 0.0% in the prior quarter.
- Across five years, Return on Equity topped out at 0.06% in Q4 2025 and bottomed at 0.13% in Q1 2024.
- Average Return on Equity over 5 years is 0.02%, with a median of 0.02% recorded in 2022.
- The sharpest move saw Return on Equity fell -13bps in 2024, then increased 16bps in 2025.
- Year by year, Return on Equity stood at 0.02% in 2021, then grew by 9bps to 0.02% in 2022, then crashed by -396bps to 0.09% in 2023, then soared by 79bps to 0.02% in 2024, then surged by 427bps to 0.06% in 2025.
- Business Quant data shows Return on Equity for AGL at 0.06% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.